A recent paper from the University of Southampton questions the dominance of Cognitive Behavior Therapy for psychosis (CBTp) as the primary treatment and suggests that a more diverse range of individually targeted therapies could enhance outcomes for patients.
The research examines whether less complex and costly approaches might be as or more effective than CBTp, especially for individuals with early psychosis, schizophrenia-related diagnoses, and those at high risk of developing psychosis.
Key points from the paper include:
Questioning the Dominance of CBTp: While acknowledging the benefits of CBTp for some individuals, the research questions whether other therapies or refined existing therapies could better meet the needs of people with psychosis. The goal is to improve clinical, functioning, and recovery outcomes.
Psychosis and CBT: Psychosis involves perceiving or interpreting reality differently from others and may include hallucinations, delusions, and disorganized thinking. CBT helps individuals make sense of their experiences and build confidence in managing symptoms like hearing voices or paranoia.
Umbrella Reviews: The researchers examined two umbrella reviews conducted in 2019 and 2023. Umbrella reviews analyze a wide range of research papers to draw conclusions about a topic.
Nuanced Findings: The paper suggests that large-scale analysis of treatment outcomes can mask important nuances. While many benefit from CBTp, some experience only modest improvements, and others may even be harmed by it.
Individualized Approaches: The researchers propose that focusing on the therapeutic relationship and specific processes, such as addressing worry and past trauma, could lead to more effective treatment.
AI and Big Data: The paper suggests using large datasets and sophisticated AI machine learning tools to aid treatment decisions. This could include combining CBTp with other approaches, like family involvement and peer support networks.
Precision Psychological Therapies: Over the next decade, the researchers predict that continually evolving patient experience datasets will shape precision psychological therapies. These data-driven approaches aim to select evidence-based therapies tailored to individuals.
Shared Decision-Making: The paper emphasizes the importance of involving patients in treatment decisions and ensuring secure and ethical management of health data.
In summary, the study challenges the one-size-fits-all approach of CBTp for psychosis treatment and highlights the potential for AI and big data to guide more personalized and effective therapies in the future.
If you care about brain health, please read studies about how the Mediterranean diet could protect your brain health, and blueberry supplements may prevent cognitive decline.
For more information about brain health, please see recent studies about antioxidants that could help reduce dementia risk, and Coconut oil could help improve cognitive function in Alzheimer’s.
Copyright © 2024 Knowridge Science Report. All rights reserved.
